| abstract |
The present invention is represented by the general formula (1) [Chemical 1] Wherein the groups R 1 to R 7 , Q a , Q b , L, n and m are as defined in claim 1. Of the compounds (which are suitable for the treatment of diseases characterized by excessive or abnormal cell proliferation), pharmaceutical formulations containing such compounds and their use as drugs. |